Literature DB >> 12210338

Facial appearance in persistent hyperinsulinemic hypoglycemia.

Pascale de Lonlay1, Valérie Cormier-Daire, Jeanne Amiel, Guy Touati, Alice Goldenberg, Jean-Christophe Fournet, Francis Brunelle, Claire Nihoul-Fékété, Jacques Rahier, Claudine Junien, Jean-Jacques Robert, Jean-Marie Saudubray.   

Abstract

Persistent hyperinsulinism is the most common cause of recurrent hypoglycemia in infancy because of inappropriate oversecretion of insulin by the pancreas. Pancreatic lesions can be either focal or diffuse, and they have distinct molecular bases. We have studied the facial features in 17 unrelated patients presenting with neonatal (n = 8) or infancy-onset (n = 9) hyperinsulinism. Hyperinsulinism was related to focal adenomatous hyperplasia (n = 7), diffuse hyperinsulinism (n = 5), non-operated hyperinsulinism (n = 2), and hyperinsulinism with hyperammonemia (n = 3). SUR1 or Kir6.2 mutations were found in six of seven focal adenomatous hyperplasia and three of five diffuse hyperinsulinism. A loss of the maternal allele from chromosome 11p15 in the lesion was found in all focal adenomatous hyperplasia. GLUD1 mutations were found in all patients with hyperammonemia. Large birth weight (mean > 3,800 g) was consistently observed (11/17) but protruding tongue, exomphalos, or visceromegaly were never noted and Wiedemann-Beckwith syndrome could always be ruled out. All patients presented with high forehead, small nasal tip, and short columella giving the impression that the nose is large and bulbous, smooth philtrum, and thin upper lip. A square appearance to the face was more obvious in younger patients. These specific facial features, observed in patients with hyperinsulinism of various molecular mechanisms, could be the consequence of fetal intoxication by insulin. However, to date, facial anomalies have not been noted in infants of diabetic mothers and inversely, malformations that are commonly reported in infants of diabetic mothers were not present in our hyperinsulinemic patients. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210338     DOI: 10.1002/ajmg.10463

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans.

Authors:  Alexander S Banks; Jianze Li; Lisa McKeag; Marta L Hribal; Masaki Kashiwada; Domenico Accili; Paul B Rothman
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

Review 2.  What's new in metabolic and genetic hypoglycaemias: diagnosis and management.

Authors:  Vassili Valayannopoulos; Stéphane Romano; Karine Mention; Anne Vassault; Daniel Rabier; Michel Polak; Jean-Jacques Robert; Yves de Keyzer; Pascale de Lonlay
Journal:  Eur J Pediatr       Date:  2007-10-03       Impact factor: 3.183

Review 3.  Congenital hyperinsulinism: current trends in diagnosis and therapy.

Authors:  Jean-Baptiste Arnoux; Virginie Verkarre; Cécile Saint-Martin; Françoise Montravers; Anaïs Brassier; Vassili Valayannopoulos; Francis Brunelle; Jean-Christophe Fournet; Jean-Jacques Robert; Yves Aigrain; Christine Bellanné-Chantelot; Pascale de Lonlay
Journal:  Orphanet J Rare Dis       Date:  2011-10-03       Impact factor: 4.123

4.  Relative expression of a dominant mutated ABCC8 allele determines the clinical manifestation of congenital hyperinsulinism.

Authors:  Ruth Shemer; Carmit Avnon Ziv; Efrat Laiba; Qing Zhou; Joel Gay; Sharona Tunovsky-Babaey; Show-Ling Shyng; Benjamin Glaser; David H Zangen
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

5.  Surgical management of congenital hyperinsulinism in a resource-limited setting.

Authors:  Santosh B Kurbet; Gowda Parameshwar Prashanth; Vijay C Pujar; Manisha R Bhandankar; Sangappa M Dhaded; Mahantesh V Patil
Journal:  J Neonatal Surg       Date:  2013-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.